FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/12/2023
Voltar para busca
Dado oficial do USPTO
MNEMO THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079330694Classe
1, 5, 10, 40, 42, 44
Pedido
79330694
Registro
7152728
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
26/12/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 40, 42, 44
Data de depósito
14/09/2021
Data de registro
05/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/09/2023
Última transação
05/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
CHANG, BETTY
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a hummingbird design in the colors purple, blue, green and yellow and the stacked wordings "MNEMO" in purple and "THERAPEUTICS" in green.
Titulares e representantes
Titulares
M. T. (pessoa física)
Representantes
Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions
Classe 5
Pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for the treatment of cancer and tumors using immunotherapy; therapeutic preparations being solutionsantigenantibodiesT-cells in the nature of preparations for treatment of cancer and tumors; biological materialspreparationsreagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; antigensantibodiescells for therapeutic use
Classe 10
apparatus and instruments for carrying out tests and diagnostics for medical usemedical imagingbiopsiesgenetic and molecular analysis ; medical apparatus and instruments for identifyingscreeninganalyzing antigens for medical use; medical apparatus for reading of analytical testsnamely molecularblood and genetic testing
Classe 40
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; Custom manufacturing of antigensantibodiesT-cells; Providing manufacturing information in the field of pharmaceuticals
Classe 42
Scientific research services for medical purposesmedical research; Scientific research and development services for identifyingscreening and developing antigens; scientific and technological servicesscientific researchanalysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific information with regard to immunotherapy; Scientific research and development servicesproviding services for the identificationanalysisauthenticationpurification and development of biological material from a genomic platform; Scientific researchepigenetic antigen identification and screening services for therapeutic research purposes; Scientific researchgenomic and epigenetic characterization services for identifying drug candidates in immunotherapy; Scientific and medical research servicesdesigning algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cellsantigenstissuesgene expressionsgene sequencesgenome annotationsantigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteristics of antigens and immunological responses
Classe 44
Providing medical information with regard to immunotherapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/12/2023
FIMP
FINAL DISPOSITION PROCESSED
06/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/06/2023
PUBO
PUBLISHED FOR OPPOSITION
20/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
19/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
31/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/05/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/05/2023
RFNP
REFUSAL PROCESSED BY IB
19/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/03/2023
GNRT
NON-FINAL ACTION E-MAILED
16/03/2023
CNRT
NON-FINAL ACTION WRITTEN
16/03/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
16/03/2023
RINX
USPTO CORRECTION PROCESSED BY IB
05/03/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
05/03/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/02/2023
GNFR
FINAL REFUSAL E-MAILED
01/02/2023
CNFR
FINAL REFUSAL WRITTEN
01/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/01/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/01/2023
CRSN
CORRECTION SENT TO IB
12/12/2022
CRCR
CORRECTION CREATED FOR IB
07/12/2022
RFNT
REFUSAL PROCESSED BY IB
23/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/07/2022
RFRR
REFUSAL PROCESSED BY MPU
29/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/07/2022
CNRT
NON-FINAL ACTION WRITTEN
05/07/2022
DOCK
ASSIGNED TO EXAMINER
17/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MNEMO THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.